UMass Medical School will bring the UMass Center for Clinical and Translational Science to its next level of innovation and collaboration with the five-year, $30 million renewal of its Clinical and Translational Sciences Award from the National Institutes of Health. The center advances clinical and translational research through education and training, pilot funding programs, research cores, and services.
A new study by researchers at MassBiologics of UMass Medical School published in Nature Communications suggests that COVID specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus—a potentially critical feature of an effective vaccine.
The Massachusetts Life Sciences Center (MLSC) has announced more than $15 million in capital funding to support life sciences innovation infrastructure, the development of key data repositories and training for scientists across the commonwealth.
Humans are not the only species facing a potential threat from SARS-CoV-2, the novel coronavirus that causes COVID-19, according to a new study from scientists at the University of Massachusetts Medical School and the University of California, Davis.
A UMass Medical School professor is co-directing a first-of-its-kind national program to enhance diversity in the academic biomedical workforce, funded by a $1.3 million, five-year grant from the National Institutes of Health to create skills development workshops, mentor training opportunities and institutional culture-change initiatives at universities.
A UMass Medical School infectious disease specialist is urging people to get vaccinated soon against influenza, as the threat approaches of what has been called a “twindemic,” the annual spike in seasonal flu coinciding this year with the ongoing COVID-19 pandemic.
UMass Medical School is enrolling healthy volunteers to take part in a Phase II/III clinical trial testing whether a messenger RNA (mRNA) vaccine candidate can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19). The trial, by Pfizer and BioNTech, follows review of preclinical and clinical data from a Phase I trial, which assessed safety, tolerability and immune response in a group of volunteers.
Christian Rojas, professor in the department of resource economics, has received a Fulbright U.S. Scholar Program award to Malta. Rojas will be studying the impact of the hotel industry in the Maltese economy as well as the impact of the recent rise of the sharing economy (i.e. Airbnb) on the formal lodging industry. Of special interest will be quantifying the effect of, and prospects for recovery after, the COVID-19 pandemic. In addition, Rojas will be teaching an applied game theory course at the University of Malta.
AMHERST, Mass. – An international task force, including two University of Massachusetts Amherst computer scientists, concludes in new research that mobile health (mHealth) technologies are a viable option to monitor COVID-19 patients at home and predict which ones will need medical intervention.
Professor Friederike Jentoft, department of chemical engineering, has been awarded a $550,000 U.S. Department of Energy’s Office of Science Financial Assistance Program to continue her work on acid catalyst design.
Acid catalysis plays a key role in commercially established and emerging processes for the transformation of petroleum- or biomass-derived feedstocks to chemicals and fuels. Jentoft’s project focuses on acid-catalyzed processes that are characterized by long-lived surface species, which are often trapped in the pores of a solid catalyst.